CALL US
+91 9891296838/9811747774

ENHERTU (fam-trastuzumab deruxtecan-nxki) for injection,
for intravenous use. Initial U.S. Approval: 2019 Available In India.

ENHERTU is a prescription medicine. ENHERTU is used to treat (HER2)-positive breast cancer. If you have questions, please email IPN Support Team or Call Indian Pharma Network on +91 9891296838 (Mr. Tarun) / 9811747774 (Mr. Neeraj) for price list or cost in India.

ENHERTU is a prescription medicine. ENHERTU is used to treat human epidermal growth factor receptor 2 (HER2)-positive breast cancer that cannot be removed by surgery or that has spread to other parts of your body (metastatic), and who have received two or more prior anti-HER2 breast cancer treatments.. ENHERTU is a HER2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting.
This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
Source content : www.accessdata.fda.gov

ENHERTU (fam-trastuzumab deruxtecan-nxki)injection suppliers for India and other countries. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of ENHERTU (fam-trastuzumab deruxtecan-nxki)injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the ENHERTU (fam-trastuzumab deruxtecan-nxki)injection medicine cost price in India.

The order for ENHERTU (fam-trastuzumab deruxtecan-nxki)injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Trastuzumab deruxtecan also known as fam-trastuzumab deruxtecan and sold under the brand name Enhertu, is a medication used for the treatment of adults with unresectable (unable to be removed with surgery) or metastatic (when cancer cells spread to other parts of the body) HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting.

Trastuzumab deruxtecan is an antibody-drug conjugate that includes a human epidermal growth factor receptor 2 (HER2)-directed antibody trastuzumab and a topoisomerase I inhibitor conjugate deruxtecan (a derivative of exatecan). It was approved for use in the United States in December 2019.

ENHERTU (fam-trastuzumab deruxtecan-nxki) injection, for intravenous use.
Initial U.S. Approval: 2019

For injection: 100 mg lyophilized powder in a single-dose vial
Please see the Full Prescribing Information, including Patient Information, for ENHERTU.
ENHERTU (fam-trastuzumab deruxtecan-nxki)injection
You must agree before submitting.

News / Update for ENHERTU (fam-trastuzumab deruxtecan-nxki).

For ENHERTU (fam-trastuzumab deruxtecan-nxki)Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Enhertu bags EU approval for HER2-positive breast cancer For More Details

FDA approves Enhertu for gastric cancer subset For More Details

Steps to access ENHERTU (fam-trastuzumab deruxtecan-nxki) tablets.

Step 1. You send a request for your medicine online:- Submit a request for a specific medicine, or a general request, and your Patient Support Manager will contact you within 24 hours. They will be there to support and guide you in anyway possible to help you get the medicine you need.

Step 2. We verify your prescription and medical details:- Since we help patients access medicines not available in their home country, our first step is to check that the medicine you need is not currently available in your home country. Next we will also verify that you have a prescription from a doctor in your home country for the medicine you need.

Step 3. We source your medicine:- Once we have verified your prescription and medical details, our expert sourcing team will work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.

Step 4. We deliver your medicine:- After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine.

Documentation under Named-Patient import

Doctor’s Prescription –
We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.

Patient’s Medical history –
We would require all test reports and medical reports of the patient for last 3 months.

Patient’s Identity card –
We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

ENHERTU (fam-trastuzumab deruxtecan-nxki)exporter and suppliers in India

Can I get anti-cancer medicines even if I am not based in India?
Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. Indian Pharma Network, New Delhi can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of -
ENHERTU (fam-trastuzumab deruxtecan-nxki)in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
ENHERTU (fam-trastuzumab deruxtecan-nxki)in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
ENHERTU (fam-trastuzumab deruxtecan-nxki)in North America – Mexico.
ENHERTU (fam-trastuzumab deruxtecan-nxki)in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
ENHERTU (fam-trastuzumab deruxtecan-nxki)in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
ENHERTU (fam-trastuzumab deruxtecan-nxki)in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
ENHERTU (fam-trastuzumab deruxtecan-nxki)in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
ENHERTU (fam-trastuzumab deruxtecan-nxki)in Australia and New Zealand.

Room temperature shipping

For this medication, standard shipping applies. This means that a consistent room temperature of 15 to 25°C is maintained during transit.

Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised cold chain couriers. If you would like your order to be shipped by a specific courier, please inform us when you place the order. Our standard delivery time varies from 5 to 10 working days. The shipping cost depends on the medicine and the destination country. After making an enquiry, you will receive a detailed quote that includes the shipping costs.

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur